Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chad Briscoe

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Bioanalysis|November 5, 2013
New setting for the Land O'Lakes Bioanalytical ConferenceJames E DeMuth, Stacy Ho, Chad Briscoe, et al.
Rapid Communications in Mass Spectrometry : RCM|October 20, 2006
A general approach for the quantitative analysis of bisphosphonates in human serum and urine by high-performance liquid chromatography/tandem mass spectrometryLee S Zhu, Veniamin N Lapko, Jean W Lee, et al.
Bioanalysis|October 12, 2011
Conference report: 12th Annual University of Wisconsin Land O'Lakes Bioanalytical ConferenceJames E DeMuth, Chad Briscoe, Lakshmi Amaravadi, et al.
Bioanalysis|November 19, 2010
Summary of the Eleventh Annual University of Wisconsin Land O'Lakes Bioanalytical ConferenceJames E Demuth, Michael J Hayes, Lakshmi Amaravadi, et al.
Bioanalysis|November 19, 2010
Formation of a Global Contract Research Organization Council for BioanalysisNoel Premkumar, Stephen Lowes, James Jersey, et al.
Bioanalysis|October 8, 2016
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV) (Part 1 - small molecules, peptides and small molecule biomarkers by LCMS)Eric Yang, Jan Welink, Stephanie Cape, et al.
Bioanalysis|November 18, 2017
2017 White Paper on recent issues in bioanalysis: aren't BMV guidance/guidelines 'Scientific'? (Part 1 - LCMS: small molecules, peptides and small molecule biomarkers)Jan Welink, Eric Yang, Nicola Hughes, et al.
Bioanalysis|December 14, 2019
2019 White Paper On Recent Issues in Bioanalysis: FDA BMV Guidance, ICH M10 BMV Guideline and Regulatory Inputs (<u>Part 2</u> - Recommendations on 2018 FDA BMV Guidance, 2019 ICH M10 BMV Draft Guideline and Regulatory Agencies' Input on Bioanalysis, Biomarkers and Immunogenicity)Brian Booth, Lauren Stevenson, Renuka Pillutla, et al.
Bioanalysis|February 27, 2016
9th GCC closed forum: CAPA in regulated bioanalysis; method robustness, biosimilars, preclinical method validation, endogenous biomarkers, whole blood stability, regulatory audit experiences and electronic laboratory notebooksRoger Hayes, Richard LeLacheur, Isabelle Dumont, et al.
Bioanalysis|July 20, 2019
12th GCC Closed Forum: critical reagents; oligonucleotides; CoA; method transfer; HRMS; flow cytometry; regulatory findings; stability and immunogenicityChad Briscoe, Nicola Hughes, Roger Hayes, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Bioanalysis|November 5, 2013
New setting for the Land O'Lakes Bioanalytical ConferenceJames E DeMuth, Stacy Ho, Chad Briscoe, et al.
Rapid Communications in Mass Spectrometry : RCM|October 20, 2006
A general approach for the quantitative analysis of bisphosphonates in human serum and urine by high-performance liquid chromatography/tandem mass spectrometryLee S Zhu, Veniamin N Lapko, Jean W Lee, et al.
Bioanalysis|October 12, 2011
Conference report: 12th Annual University of Wisconsin Land O'Lakes Bioanalytical ConferenceJames E DeMuth, Chad Briscoe, Lakshmi Amaravadi, et al.
Bioanalysis|November 19, 2010
Summary of the Eleventh Annual University of Wisconsin Land O'Lakes Bioanalytical ConferenceJames E Demuth, Michael J Hayes, Lakshmi Amaravadi, et al.
Bioanalysis|November 19, 2010
Formation of a Global Contract Research Organization Council for BioanalysisNoel Premkumar, Stephen Lowes, James Jersey, et al.
Bioanalysis|October 8, 2016
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV) (Part 1 - small molecules, peptides and small molecule biomarkers by LCMS)Eric Yang, Jan Welink, Stephanie Cape, et al.
Bioanalysis|November 18, 2017
2017 White Paper on recent issues in bioanalysis: aren't BMV guidance/guidelines 'Scientific'? (Part 1 - LCMS: small molecules, peptides and small molecule biomarkers)Jan Welink, Eric Yang, Nicola Hughes, et al.
Bioanalysis|December 14, 2019
2019 White Paper On Recent Issues in Bioanalysis: FDA BMV Guidance, ICH M10 BMV Guideline and Regulatory Inputs (<u>Part 2</u> - Recommendations on 2018 FDA BMV Guidance, 2019 ICH M10 BMV Draft Guideline and Regulatory Agencies' Input on Bioanalysis, Biomarkers and Immunogenicity)Brian Booth, Lauren Stevenson, Renuka Pillutla, et al.
Bioanalysis|February 27, 2016
9th GCC closed forum: CAPA in regulated bioanalysis; method robustness, biosimilars, preclinical method validation, endogenous biomarkers, whole blood stability, regulatory audit experiences and electronic laboratory notebooksRoger Hayes, Richard LeLacheur, Isabelle Dumont, et al.
Bioanalysis|July 20, 2019
12th GCC Closed Forum: critical reagents; oligonucleotides; CoA; method transfer; HRMS; flow cytometry; regulatory findings; stability and immunogenicityChad Briscoe, Nicola Hughes, Roger Hayes, et al.
Pageof 3